Softwr

Healthcare · head to head

Lunit vs OpenMRS

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
OpenMRS logo

OpenMRS

Healthcare

Open source electronic medical record platform for low-resource settings, with no vendor and paid implementers instead

From
Free
Rated
-
Full reviewWebsite

The short version

  • Only OpenMRS has a free tier, so it costs nothing to try first.
  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; OpenMRS there is no vendor and no support contract from OpenMRS itself, so a procurement that requires a named supplier with a service level must instead contract an implementer, and the quality of that implementer determines the outcome more than the software does
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, OpenMRS covers Concept dictionary.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and OpenMRS actually diverge.

Attributes where Lunit and OpenMRS differ
AttributeLunitOpenMRS
Starting priceOn requestFree
Pricing modelquoteOpen source, no licence fee
Free tierNoYes
PlatformsWebLinux, Web, Windows

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in OpenMRS

  • Concept dictionary
  • Modular architecture
  • Modern front end
  • FHIR support
  • Offline tolerance
  • Patient matching and registration
  • Distributions

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot OpenMRS
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot OpenMRS
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot OpenMRS
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot OpenMRS

OpenMRS

  • A ministry of health standardising HIV treatment records across hundreds of facilities where per-patient licensing would be unaffordablenot Lunit
  • A hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirementsnot Lunit
  • An NGO running a tuberculosis programme that must report into DHIS2 and needs the clinical record beneath it to be modifiablenot Lunit
  • A health system that wants to own its clinical data model outright rather than depend on a vendor to extend itnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

OpenMRS

  • There is no vendor and no support contract from OpenMRS itself, so a procurement that requires a named supplier with a service level must instead contract an implementer, and the quality of that implementer determines the outcome more than the software does
  • It is a framework rather than a ready product, so a deployment requires clinical content, form design, concept dictionary work and integration before a single patient is registered, and that work is months of skilled effort
  • Funding comes largely from donor programmes, which makes the pace of core development dependent on grant cycles rather than on a commercial roadmap, and priorities can shift when a funder does
  • Distribution choice, core OpenMRS against Bahmni against Ozone, locks in a different set of components and a different implementer pool, and migrating between distributions later is close to a fresh implementation
  • The people cost never goes away: a national deployment needs permanent internal informatics capacity or a permanent support contract, and organisations that budget only the zero licence fee run out of money at the point the system becomes clinically critical

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

OpenMRS

Free
  • OpenMRSFree
    • Openly licensed, no licence fee and no seat limits
    • Community support through forums and the OpenMRS Talk platform
    • No support contract available from OpenMRS itself

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose OpenMRS if

  • You need concept dictionary.
  • You want to start without paying.
  • You work on Linux, Web, Windows.
  • You also want modular architecture.
OpenMRS review

Questions people ask

Is Lunit or OpenMRS better?
Neither clearly leads. Lunit starts at On request and OpenMRS at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or OpenMRS?
OpenMRS has a free tier; the other does not. Paid plans start at On request for Lunit and Free for OpenMRS.
Does Lunit or OpenMRS run on more platforms?
Lunit runs on Web. OpenMRS runs on Linux, Web, Windows.
Can I use OpenMRS for free?
Yes. OpenMRS has a free tier, so you can try it without paying. Lunit starts at On request.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what OpenMRS is typically brought in for.
What can Lunit do that OpenMRS cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. OpenMRS covers Concept dictionary, Modular architecture, Modern front end, FHIR support.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

OpenMRS: Who supports OpenMRS if it breaks?

Not OpenMRS itself. Support is bought from implementers such as Mekom Solutions, which offers long-term production service level agreements for OpenMRS, Bahmni and Ozone deployments, or from regional partners.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

OpenMRS: Is it really free?

The software has no licence fee. Hosting, configuration, clinical content, integration and support are the real cost, and they are ongoing.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

OpenMRS: What is the difference between OpenMRS, Bahmni and Ozone?

OpenMRS is the core platform. Bahmni and Ozone are distributions that package it with billing, laboratory and inventory components. Choosing a distribution constrains your implementer options.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

OpenMRS: Does it support FHIR?

Yes. FHIR support is the standard route for integrating laboratory, pharmacy and national reporting systems.

Share

Related pages

More on Lunit

More on OpenMRS

Keep looking

Other head to heads